Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Dayvigo - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Dayvigo

Approved

STANDARD

Dayvigo

Eisai Manufacturing Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: e72feac9f5b61df2
Company: Eisai Manufacturing Limited
Type: Standard

Approval Details

Approval Id: e72feac9f5b61df2
Drug Approval Philippines Name: Dayvigo
Product Name: Dayvigo
Registration Number: DR-XY47691
Brand Name: Dayvigo
Generic Name: Lemborexant
Dosage Form: Film-Coated Tablet
Dosage Strength: 10mg
Manufacturer: Eisai Manufacturing Limited
Importer: HI-Eisai Pharmaceutical, Inc.
Distributor: Zuellig Pharma Corporation
Company Detail Path: /organization/eisai-manufacturing-limited
Issuance Date: 28 January 2022
Expiry Date: 28 January 2027
Pharmacologic Category: Orexin Receptor Antagonist
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

e72feac9f5b61df2

Type

Standard

Back to Philippines FDA Approvals